Breast Cancer Clinical Trial

Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy

Summary

The objective of the proposed research is to develop new diagnostic modalities based on optical spectroscopy (auto fluorescence, absorption, and scattering) for the diagnosis of breast cancer and test its performance as an adjunct to core needle biopsy. For the surgery part of the study, all patients scheduled to have a mastectomy or lumpectomy for the treatment of breast cancer will be asked if they would be willing to participate in this study. For the core needle biopsy part of the study, patients with a higher pre-probability of cancer (based on mammography) will be recruited to increase the number of patients with malignant lesions and enrolled in this investigation.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients having a needle biopsy of a breast mass

Exclusion Criteria:

none

Study is for people with:

Breast Cancer

Estimated Enrollment:

213

Study ID:

NCT00734838

Recruitment Status:

Completed

Sponsor:

Duke University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Duke University Medical Center
Durham North Carolina, 27708, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

213

Study ID:

NCT00734838

Recruitment Status:

Completed

Sponsor:


Duke University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.